Advertise on podcast: Lung Cancer Considered

LCC in Spanish: ESMO 2026 Highlights En este episodio en español de Lung Cancer Considered, la Dra. Narjust Florez conversa con la Dra. Ana Velázquez Mañana sobre los principales avances en la investigación del cáncer de pulmón presentados en ESMO 2026 en Madrid. Destacan los resultados de los estudios DeLLphi-305, SAFFRON y Krascendo 1, explorando los avances en el tratamiento del cáncer de pulmón de células pequeñas y las terapias dirigidas para el cáncer de pulmón de células no pequeñas con mutaciones de EGFR y KRAS G12C. La conversación también aborda el estudio MOIO y sus implicaciones para los intervalos de administración de la inmunoterapia, la seguridad de los tratamientos y la práctica clínica. In this Spanish-language episode of Lung Cancer Considered, host Dr. Narjust Florez welcomes Dr. Ana Velázquez Mañana to discuss key lung cancer research presented at ESMO 2026 in Madrid. They highlight findings from the DeLLphi-305, SAFFRON, and Krascendo 1 trials, exploring advances in small cell lung cancer treatment and targeted therapies for EGFR-mutated and KRAS G12C-mutated non-small cell lung cancer. The conversation also examines the MOIO trial and its implications for immunotherapy dosing intervals, treatment safety, and clinical practice.

In this episode of Lung Cancer Considered, Drs. Jacob Sands, Ferdinandos Skoulidis, and Jarushka Naidoo discuss key research highlights from ESMO 2026, including results from the DeLLphi-305 trial evaluating tarlatamab in extensive-stage small cell lung cancer and the KRAScendo-1 trial investigating divarasib in KRAS G12C-mutated NSCLC. The discussion also explores emerging immunotherapy strategies, including findings from the MOIO and OptiTROP-Lung06 studies, advances in predicting immune-related toxicities, and the potential implications of these developments for clinical practice. Jaruska Naidoo, MD Professor of Medical Oncology Royal College of Surgeons Consultant, Medical Oncologist at Beaumont Hospital X: @DrJNaidoo Instagram: jarushkanaidoo LinkedIn: https://www.linkedin.com/in/jarushka-naidoo-127a3b97/ Jacob Sands, MD Assistant Professor of Medicine, Harvard Medical School Associate Chief, Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute X: @sands_jacob Instagram: jacobsands LinkedIn: https://www.linkedin.com/in/jacobsands/ Ferdinandos Skoulidis, MD, PhD Professor, Department of Thoracic and Head and Neck Medical Oncology University of Texas MD Anderson Cancer Center

In this Georgian-language episode of Lung Cancer Considered, Dr. Elene Mariamidze is joined by Dr. Mariam Tchiabrishvili and Dr. Lasha Khmaladze for a multidisciplinary discussion of a challenging case of EGFR-mutated non-small cell lung cancer (NSCLC). Through a case-based discussion, they explore molecular testing, treatment strategies, management of brain metastases, and the role of EGFR tyrosine kinase inhibitors (EGFR TKIs), while highlighting evolving treatment options and challenges in accessing care in Georgia. Guests: Elene Mariamidze, MD Clinical Oncologist, Todua Clinic President of Georgian School of Oncology (GSO) Mariam Tchiabrishvili, MD Radiation Oncologist Todua Clinic Tbilisi State University

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Nagla Karim moderates a discussion in Arabic about highlights from the conference with Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Kamal Al-rabi, Dr. Myriam Saadi, Dr. Ahmed Magdy Rabea, and Dr. Hussein Soudy. Guests: Nagla Karim, MD Professor of Medicine Director of Thoracic Oncology and Phase I Programs George Washington University Riad Abdel Jalil, MD Thoracic Surgeon King Hussein Cancer Center Bashir Abu Aqeel, MD Medical Oncologist Augusta Victoria Hospital Kamal Al-rabi, MD Medical Oncology King Hussien Cancer Center Ahmed Magdy Rabea Assistant Professor of Medical National Cancer Institute, Cairo University Myriam Saadi, MD Assistant Professor of Medical Oncology, University of Tunis el Manar Faculty of Medicine of Tunis, Department of Medical Oncology Abderrahman Mami Hospital Hussein Soudy, MBBS, PhD Senior Consultant, Medical Oncology St. George & Sutherland Hospitals, Sydney

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, guest host Dr. Kuan Yu Chen moderates a discussion in Mandarin with Dr. Bin-Chi Liao, Dr. Mong-Wei Lin, and Dr. Po-Lan Su, leading lung cancer experts in Taiwan, who share their perspectives on key highlights from the conference. Guests: Kuan-Yu Chen, MD, PhD Clinical Professor and Chief, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine National Taiwan University Hospital and College of Medicine Bin-Chi Liao, MD Department of Medical Oncology National Taiwan University Cancer Center Mong-Wei Lin, MD, PhD Professor of Surgery, National Taiwan University College of Medicine Chief, Division of Thoracic Surgery National Taiwan University Hospital Dr. Po-Lan Su, MD, PhD Clinical Associate Professor, Department of Internal Medicine National Chung Kung University Hospital, Taiwan

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Ory Wiesel moderates a discussion in Hebrew with Dr. Jair Bar, Dr. Nir Peled, and Dr. Hadas Sorotsky about highlights from the conference.

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers. Dr. Sara Fra, Dr. Cassio Murilo Hidalgo Filho, and Dr. Nan Sethakorn discuss the research presented at the meeting, the value of bringing together a multidisciplinary and international community, and the networking opportunities that helped them connect with colleagues across specialties. They reflect on their experiences in the IASLC Academy and highlight specific career development opportunities including mentorship, grants, research support, and the Early Career Forum. Guests: Sara Fra, MD Thoracic Surgeon Department of Thoracic Surgery Ramón y Cajal University Hospital Cassio Murilo Hidalgo Filho, MD Medical Oncology, Postdoctoral Fellow Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute Harvard Medical School Nan Sethakorn, MD, PhD Thoracic Oncologist Basic Translational Researcher Loyola University Chicago

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul. In this episode, Dr. Nagla Karim discusses highlights from the workshop in Arabic with Dr. Hesham Elghazaly, Dr. Arafat Tfayli, Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Adda Bounedjar, and Dr. Rasha Aboelhassan. Guests: Nagla Karim, MD Professor of Medicine Director of Thoracic Oncology and Phase I Programs George Washington University Hesham Elghazaly, MD Professor of Clinical Oncology Ain Shams University Arafat Tfayli, MD Chief of Hematology/Oncology and Professor of Clinical Medicine American University of Beirut Medical Center Bashir Abu Aqeel, MD Medical Oncologist Augusta Victoria Hospital Riad Abdel Jalil, MD Thoracic Surgeon King Hussein Cancer Center Adda Bounedjar, MD Professor of Medical Oncology Blida 1 University Rasha Aboelhassan, MD Senior Oncology Consultant Nasser Institute for Research and Treatment

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the conference with Dr. Ji-Youn Han, Dr. Tae Min Kim, and Dr. Sehhoon Park. Guests: Ji-Youn Han, MD, PhD Professor National Cancer Center of Korea X: @oncologyhan Tae Min Kim, MD, PhD Professor Seoul National University Hospital No Social Sehhoon Park, MD, PhD Division of Hematology-Oncology, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine LinkedIn: https://www.linkedin.com/in/sehhoon-park/

In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that caught their attention at the meeting. They reflect on access to new therapies, the importance of involving patient advocates early in clinical trial design, and how stronger communication between patients and providers can improve care. Plus, hear what they look for in new research and their perspectives on topics such as survivorship research and exercise oncology. Guests: Dr. Sydney Barned Physician and Patient Advocate Living with Stage IV ALK-positive lung cancer Yvonne Diaz Co-founder and Chair, Oncogene Cancer Research Board Member, ALK Positive Inc.

Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and clinical expertise between the regions. Dr. Chul Kim, Dr. Stephen Liu, Dr. Yuanyuan Zhao, and Dr. Caicun Zhou discuss key research highlights presented at WCLC and explore why lung cancer research is advancing rapidly in China, plus how stronger global collaboration can shape the future of thoracic oncology. Guests: Dr. Chul Kim Director of Thoracic Oncology Georgetown University, Washington, DC Dr. Yuanyuan Zhao Medical Oncologist & Chief Physician Sun Yat-Sen University Cancer Center Dr. Caicun Zhou Professor, Chief Physician, and Director of Medical Oncology Shanghai Pulmonary Hospital, Tongji University School of Medicine

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and lung cancer screening — with a focus on what APPs can take back to the clinic. Laura Macke, Stephanie McDonald, and Dr. Mary Pasquinelli discuss the studies and advances that caught their attention, including how these developments will affect patient conversations, treatment decisions, and the day-to-day work of APPs. Guests: Laura A. Macke, MS, FNP-C, AOCNP Nurse Practitioner Medstar Georgetown Cancer Institute Washington, DC Stephanie McDonald, MSN, FNP-BC, AOCNP Thoracic Oncology Nurse Practitioner Dana-Farber Cancer Institute Boston, MA Mary Pasquinelli, DNP, APRN, CTTS Lead Nurse Practitioner and Director of the Lung Screening Program University of Illinois Chicago

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Marie Drösslerová moderates a discussion in Czech about breakthrough advances in thoracic oncology presented at the conference with Dr. Fernando Casas Mendez and Dr. Martin Svaton. Guests: Marie Drösslerová, MD Clinical Oncologist and Pulmonologist, Department of Pulmonology, First Faculty of Medicine Charles University/Thomayer University Hospital, Prague Fernando Casas Mendez, MD Pulmonologist, Center for Thoracic Oncology and Surgery & National Oncology Center University Hospital Motol and Homolka, Prague Martin Svaton, Ph.D. Department of Pneumology and Phtiseology University Hospital in Pilsen

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Narjust Florez moderates a discussion in Spanish about breakthrough advances in thoracic oncology presented at the conference with Dr. Jorge Alatorre Alexander and Dr. Miguel Gonzalez Velez. Guests: Jorge Alatorre Alexander, MD Head of the Medical Oncology Service National Institute of Respiratory Diseases (INER) Miguel Gonzalez Velez, MD Medical Oncologist John Theurer Cancer Center at Hackensack University Medical Center

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about breakthrough advances in thoracic oncology presented at the conference with Dr. Lilian Faroni and Dr. Vladmir Cordeiro de Lima. Guests: Lilian Faroni, MD, PhD Radiation Oncologist Oncologia D’Or Rio de Janeiro, Brazil Vladmir Cordeiro de Lima, MD, PhD Thoracic and Breast Oncologist A.C. Camargo Cancer Center, São Paulo, Brazil